Doximity details governance to mitigate clinical AI bias
Head of Health Equity Félix Manuel Chinea outlines how Doximity Ask prevents bias, grounding dermatologic descriptions across the Fitzpatrick scale and flagging omissions.
See the latest news and media coverage for Doximity. We track all announcements, press releases, and industry mentions in real time, all in one place.
Network and productivity platform for U.S. clinicians
doximity.comLast updated
In short: Doximity reported strong financial growth and expanded its clinical AI capabilities while addressing legal settlements and safety trials.
Head of Health Equity Félix Manuel Chinea outlines how Doximity Ask prevents bias, grounding dermatologic descriptions across the Fitzpatrick scale and flagging omissions.
The mode supports evidence-based clinical reasoning, weighing factors like ICU scenarios and comorbidities. Users can select it or let Ask switch automatically.
Searches rose over 15,000% above baseline, climbing in June and surging in July after CDC and FDA alerts, helping physicians access current information.
The Stanford-Harvard collaboration enables rigorous third-party studies on US doctors' AI use. Doximity shares Katie Palmer's STAT article on the industry.
Doximity Inc. DOCS stock surged Friday after the digital healthcare company reported fiscal first-quarter results that topped revenue expectations and raised its full-year sales outlook...
CEO Jeff Tangney said Doximity's AI recorded a 4.8% error rate versus 13.6% for Anthropic's Fable 5.
Shares of Doximity (DOCS), which runs a medical networking platform, were surging 50% on Friday morning after being up as much as 94% earlier in...
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per...
Track Doximity and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.